GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹17 Cr | ₹17 Cr | ₹4.69 Cr | ₹5.38 Cr | ₹6.53 Cr |
What is the latest Operating Profit of GENNEX LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹17 Cr |
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹4.69 Cr |
| Mar2023 | ₹5.38 Cr |
| Mar2022 | ₹6.53 Cr |
How is Operating Profit of GENNEX LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 Cr | -1.97 | |
| Mar2025 | ₹17 Cr | 262.88 | |
| Mar2024 | ₹4.69 Cr | -12.74 | |
| Mar2023 | ₹5.38 Cr | -17.68 | |
| Mar2022 | ₹6.53 Cr | - | |
Compare Operating Profit of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹223.2 Cr | -2.3% | -5.6% | -37.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -2.3% |
-5.6% |
-37.4% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses